FDA Approved: LISINOPRIL — Supplemental Application (Exelan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental application for lisinopril submitted by Exelan Pharmaceuticals Inc., typically resulting in labeling updates or related changes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Heart Failure
• Hypertension
• Myocardial Infarction

Drugs mentioned

• Lisinopril (Lisinopril)

Snippet

SUPPL AP for LISINOPRIL (LISINOPRIL)